The challenge: Estimating the threat of existing and potential generic competitors.
A major Pharmaceutical company approached LucidQuest for support with monitoring known competitors and additional generic entrants, along with their ability to meet their target timelines and the likelihood of at-risk launch.
The Action: Primary and secondary research to identify the competition and targeted monitoring.
LucidQuest conducted extensive primary and secondary research and identified all potential generic manufacturers and their plans to enter a crowded field.
Working with the client, LucidQuest then monitored a selection of key potential entrants for their manufacturing capabilities and “appetite” for at-risk launches.
The Result: Realistic view of competitive threats and court actions settling.
The client gained a realistic view of competitive threats as LucidQuest removed any existing concerns over an unlikely at-risk launch.
Our client also received a list of identified additional potential generic competitors that have since been sporadically monitored without posing a serious threat.
Finally, the client utilized this intelligence in their decision process to settle certain court actions with some potential competitors.
#generics #genericsmanufacturing #competitiveintelligence #druglaunch #ourwork #casestudy